MapLight Therapeutics Ownership & Insider Activity

MapLight Therapeutics (MPLT) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 5.6% of shares outstanding. Institutional investors hold 16.8%. Over the past 90 days, insiders made 1 purchase worth $149K and 2 sales worth $470K.

Shares Outstanding

55.576M

Shares Float

32.229M

Insider Shares Owned

3.100M

Insider % Owned

5.6%

Institutional Shares Held

9.354M

Institutional % Held

16.8%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

$149K total

Sales (90d)

$470K total

Net Activity

Net Selling

Net Value (90d)

-$321K

MapLight Therapeutics Insider Transactions (Last 6 Months)

See all insider trades →

Date	Insider	Title	Type	Shares	Price	Value
Sep 16, 2026	Kristopher Hanson	GENERAL COUNSEL	SELL	16.509K	$11.67	$193K
Aug 3, 2026	Woodruff James Lillie	CHIEF SCIENTIFIC OFFICER	SELL	22.082K	$12.54	$277K
Jul 28, 2026	Troy Cox	—	BUY	15.620K	$9.52	$149K
Jul 15, 2026	JONATHAN GILLIS	CAO AND INTERIM CFO	SELL	36.979K	$37.12	$1.4M
Jul 15, 2026	Anatol Kreitzer	CHIEF DISCOVERY OFFICER	SELL	36.284K	$37.09	$1.3M
Jul 15, 2026	Christopher Kroeger	CHIEF EXECUTIVE OFFICER	SELL	147.639K	$36.87	$5.4M
Jul 15, 2026	Woodruff James Lillie	CHIEF SCIENTIFIC OFFICER	SELL	18.267K	$36.88	$674K
Jul 15, 2026	Kristopher Hanson	GENERAL COUNSEL	SELL	16.508K	$36.82	$608K
Jul 15, 2026	Pennock Erin Foff	CHIEF MEDICAL OFFICER	SELL	47.158K	$36.78	$1.7M
May 18, 2026	Christopher Kroeger	CHIEF EXECUTIVE OFFICER	SELL	118.235K	$27.19	$3.2M
May 11, 2026	Kristopher Hanson	GENERAL COUNSEL	SELL	13.917K	$30.13	$419K
May 7, 2026	Christopher Kroeger	CHIEF EXECUTIVE OFFICER	SELL	68.491K	$28.47	$1.9M
May 7, 2026	Pennock Erin Foff	CHIEF MEDICAL OFFICER	SELL	4.438K	$28.54	$127K
May 7, 2026	Woodruff James Lillie	CHIEF SCIENTIFIC OFFICER	SELL	721.000	$28.28	$20K
May 4, 2026	Vishwas Setia	CHIEF FINANCIAL OFFICER	SELL	36.371K	$28.17	$1.0M
May 4, 2026	Pennock Erin Foff	CHIEF MEDICAL OFFICER	SELL	50.280K	$28.39	$1.4M
May 4, 2026	Woodruff James Lillie	CHIEF SCIENTIFIC OFFICER	SELL	51.707K	$28.40	$1.5M
May 4, 2026	Kristopher Hanson	GENERAL COUNSEL	SELL	13.917K	$27.89	$388K
May 4, 2026	Christopher Kroeger	CHIEF EXECUTIVE OFFICER	SELL	49.744K	$28.39	$1.4M
Apr 27, 2026	JONATHAN GILLIS	CAAO AND PAO	SELL	69.835K	$29.89	$2.1M
Apr 27, 2026	Anatol Kreitzer	CHIEF DISCOVERY OFFICER	SELL	45.422K	$29.66	$1.3M
Apr 15, 2026	Anatol Kreitzer	CHIEF DISCOVERY OFFICER	SELL	3.316K	$26.61	$88K
Apr 15, 2026	JONATHAN GILLIS	CAAO AND PAO	SELL	3.590K	$26.61	$96K
Apr 15, 2026	Kristopher Hanson	GENERAL COUNSEL	SELL	1.827K	$26.89	$49K
Apr 15, 2026	Vishwas Setia	CHIEF FINANCIAL OFFICER	SELL	2.922K	$26.89	$79K
Apr 15, 2026	Woodruff James Lillie	CHIEF SCIENTIFIC OFFICER	SELL	4.513K	$27.16	$123K
Apr 15, 2026	Pennock Erin Foff	CHIEF MEDICAL OFFICER	SELL	3.213K	$27.03	$87K
Apr 15, 2026	Christopher Kroeger	CHIEF EXECUTIVE OFFICER	SELL	19.187K	$27.16	$521K
Apr 15, 2026	Robert Malenka	—	SELL	8.593K	$26.90	$231K

More with Benzinga EdgeGet Access

MapLight Therapeutics Inc

MapLight Therapeutics Ownership & Insider Activity

MapLight Therapeutics Insider Transactions (Last 6 Months)

People Also Watch

People Also Watch